202 related articles for article (PubMed ID: 25900876)
1. Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
Wu L; Chaffee KG; Parker AS; Sicotte H; Petersen GM
Tumour Biol; 2015 Sep; 36(10):7431-7. PubMed ID: 25900876
[TBL] [Abstract][Full Text] [Related]
2. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
5. The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.
Santos LE; Guilhen AC; de Andrade RA; Sumi LG; Ward LS
Urol Oncol; 2011; 29(3):291-4. PubMed ID: 19523860
[TBL] [Abstract][Full Text] [Related]
6. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract][Full Text] [Related]
7. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer.
Wang M; Chu H; Lv Q; Wang L; Yuan L; Fu G; Tong N; Qin C; Yin C; Zhang Z; Xu J
Int J Cancer; 2014 Dec; 135(11):2653-60. PubMed ID: 24740636
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.
Figueroa JD; Malats N; Rothman N; Real FX; Silverman D; Kogevinas M; Chanock S; Yeager M; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; García-Closas M
Carcinogenesis; 2007 Aug; 28(8):1788-93. PubMed ID: 17557904
[TBL] [Abstract][Full Text] [Related]
9. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.
Stern MC; Van Den Berg D; Yuan JM; Conti DV; Gago-Dominguez M; Pike MC; Xiang YB; Gao YT; Cortessis VK
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3057-61. PubMed ID: 19843673
[TBL] [Abstract][Full Text] [Related]
10. DNA repair gene XRCC1 polymorphisms and bladder cancer risk.
Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
BMC Genet; 2007 Apr; 8():13. PubMed ID: 17425776
[TBL] [Abstract][Full Text] [Related]
11. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
12. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
13. [Molecular classification of urogenital cancers].
Tímár J
Magy Onkol; 2014 Sep; 58(3):157-60. PubMed ID: 25260078
[TBL] [Abstract][Full Text] [Related]
14. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder.
Chen T; Jackson C; Costello B; Singer N; Colligan B; Douglass L; Pemberton J; Deddens J; Graff JR; Carter JH
Int J Cancer; 2004 Nov; 112(3):420-5. PubMed ID: 15382067
[TBL] [Abstract][Full Text] [Related]
15. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
[TBL] [Abstract][Full Text] [Related]
17. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.
Amasyali AS; Kucukgergin C; Erdem S; Sanli O; Seckin S; Nane I
J Urol; 2012 Dec; 188(6):2398-403. PubMed ID: 23088972
[TBL] [Abstract][Full Text] [Related]
19. c.29C>T polymorphism in the transforming growth factor-β1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.
Gautam KA; Pooja S; Sankhwar SN; Sankhwar PL; Goel A; Rajender S
Cytokine; 2015 Oct; 75(2):344-8. PubMed ID: 26048435
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]